However, they have been shown to inhibit agrin-induced MuSK activation in vitro, and immunization with neural agrin caused MG symptoms in experimental animals, suggesting that these antibodies are involved in MG pathology (54, 56). The gene discussed is AGRN; the disease is myasthenia gravis.